Translocator protein blockade reduces prostate tumor growth

Clinical Cancer Research

Volumn 15, Issue 19, 2009, Pages 6177-6184

  Fafalios, Arlee ^a   Akhavan, Ardavan ^b   Parwani, Anil V ^a   Bies, Robert R ^c   McHugh, Kevin J ^a   Pflug, Beth R ^a,d  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b MOUNT SINAI HOSPITAL   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

^d INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEIN; LORAZEPAM; N SEC BUTYL 1 (2 CHLOROPHENYL) N METHYL 3 ISOQUINOLINECARBOXAMIDE; RECEPTOR PROTEIN; TRANSLOCATOR PROTEIN; TRANSLOCATOR PROTEIN RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER GROWTH; CANCER INHIBITION; CANCER TISSUE; CELL PROLIFERATION; CONTROLLED STUDY; DRUG SENSITIVITY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; PROSTATE CANCER; PROSTATE CARCINOMA; PROSTATE HYPERTROPHY; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROTEIN EXPRESSION; TUMOR XENOGRAFT;

ADENOCARCINOMA; ANIMALS; ANTINEOPLASTIC AGENTS; CARCINOMA; CELL DEATH; CELL PROLIFERATION; CELLS, CULTURED; DOWN-REGULATION; HELA CELLS; HUMANS; ISOQUINOLINES; LORAZEPAM; MALE; MICE; MICE, NUDE; PROSTATIC NEOPLASMS; RECEPTORS, GABA; TUMOR BURDEN; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 70349667466     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-09-0844     Document Type: Article

References (33)

1. Anholt RR, Pedersen PL, De Souza EB, Snyder SH. The peripheral-type benzodiazepine receptor. Localization to the mitochondrial outer membrane. J Biol Chem 1986;261:576-583
2. Papadopoulos V. Peripheral-type benzodiazepine/ diazepam binding inhibitor receptor: biological role in steroidogenic cell function. Endocr Rev 1993;14:222-240 (Pubitemid 23118419)
3. Carmel I, Fares FA, Leschiner S, Scherubl H, Weisinger G, Gavish M. Peripheral-type benzodiazepine receptors in the regulation of proliferation of MCF-7 human breast carcinoma cell line. Biochem Pharmacol 1999;58:273-278 (Pubitemid 29255945)
4. Batra S, Alenfall J. Characterization of peripheral benzodiazepine receptors in rat prostatic adenocarcinoma. Prostate 1994;24:269-278 (Pubitemid 24166956)
5. Katz Y, Eitan A, Gavish M. Increase in peripheral benzodiazepine binding sites in colonic adenocarcinoma. Oncology 1990;47:139-142 (Pubitemid 20075553)
6. Katz Y, Ben-BaruchG, Kloog Y, Menczer J, Gavish M. Increased density of peripheral benzodiazepinebinding sites in ovarian carcinomas as compared with benign ovarian tumours and normal ovaries. Clin Sci 1990;78:155-158 (Pubitemid 20084053)
7. Batra S, Iosif CS. Peripheral benzodiazepine receptor in human endometrium and endometrial carcinoma. Anticancer Res 2000;20:463-466 (Pubitemid 30189796)
8. Han Z, Slack RS, Li W, Papadopoulos V. Expression of peripheral benzodiazepine receptor (PBR) in human tumors: relationship to breast, colorectal, and prostate tumor progression. J Recept Signal Transduct Res 2003;23:225-238 (Pubitemid 37362242)
9. Brenner C, Grimm S. The permeability transition pore complex in cancer cell death. [erratum appears in Oncogene. 2006 Oct 26;25(50):6678]. Oncogene 2006;25:4744-4756
10. Hirsch T, Decaudin D, Susin SA, et al. PK11195, a ligand of the mitochondrial benzodiazepine receptor, facilitates the induction of apoptosis and reverses Bcl-2-mediated cytoprotection. Exp Cell Res 1998;241:426-434 (Pubitemid 28366568)
11. Miettinen H, Kononen J, Haapasalo H, et al. Expression of peripheral-type benzodiazepine receptor and diazepam binding inhibitor in human astrocytomas: relationship to cell proliferation. Cancer Res 1995;55:2691-2695
12. Papadopoulos V, Kapsis A, Li H, et al. Druginduced inhibition of the peripheral-type benzodiazepine receptor expression and cell proliferation in human breast cancer cells. Anticancer Res 2000;20:2835-2847 (Pubitemid 30802647)
13. Sutter AP, Maaser K, Hopfner M, Huether A, Schuppan D, Scherubl H. Cell cycle arrest and apoptosis induction in hepatocellular carcinoma cells by HMG-CoA reductase inhibitors. Synergisticantiproliferative action with ligands of the peripheral benzodiazepine receptor. J Hepatol 2005;43:808-816 (Pubitemid 41414506)
14. Maaser K, Hopfner M, Jansen A, et al. Specific ligands of the peripheral benzodiazepine receptor induce apoptosis and cell cycle arrest in human colorectal cancer cells. Br J Cancer 2001;85:1771-1780 (Pubitemid 34081526)
15. Decaudin D, Castedo M, Nemati F, et al. Peripheral benzodiazepine receptor ligands reverse apoptosis resistance of cancer cells in vitro and in vivo. Cancer Res 2002;62:1388-1393 (Pubitemid 34407797)
16. Camins A, Diez-Fernandez C, Pujadas E, Camarasa J, Escubedo E. A new aspect of the antiproliferative action of peripheral-type benzodiazepine receptor ligands. Eur J Pharmacol 1995;272:289-292
17. Braestrup C, Squires RF. Specific benzodiazepine receptors in rat brain characterized by high-affinity (3H)diazepam binding. ProcNat l Acad Sci U S A 1977;74:3805-3809 (Pubitemid 8189972)
18. Wang JK, Morgan JI, Spector S. Benzodiazepines that bind at peripheral sites inhibit cell proliferation. Proc Natl Acad SciUSA 1984;81:753-756 (Pubitemid 14199024)
19. Wang JK, Taniguchi T, Spector S. Structural requirements for the binding of benzodiazepines to their peripheral-type sites. Mol Pharmacol 1984; 25:349-351 (Pubitemid 14033953)
20. Park CH, Carboni E, Wood PL, Gee KW. Characterization of peripheral benzodiazepine type sites in a cultured murine BV-2 microglial cell line. Glia 1996;16:65-70. (Pubitemid 26350512)
21. Alenfall J, Batra S. Modulation of peripheral benzodiazepine receptor density by testosterone in Dunning G prostatic adenocarcinoma. Life Sci 1995;56:1897-1902
22. Katz Y, Amiri Z,Weizman A, GavishM. Identification and distribution of peripheral benzodiazepine binding sites in male rat genital tract. Biochem Pharmacol 1990;40:817-820 (Pubitemid 20246590)
23. van Bokhoven A, Varella-Garcia M, Korch C, Hessels D, Miller GJ. Widely used prostate carcinoma cell lines share common origins. Prostate 2001;47:38-51. (Pubitemid 32246751)
24. Delavoie F, Li H, Hardwick M, et al. In vivo and in vitro peripheral-type benzodiazepine receptor polymerization: functional significance in drug ligand and cholesterol binding. Biochemistry 2003;42:4506-4519
25. Yeliseev AA, Kaplan S. TspO of Rhodobacter sphaeroides. A structural and functional model for the mammalian peripheral benzodiazepine receptor. J Biol Chem 2000;275:5657-5667 (Pubitemid 30115205)
26. Calvo DJ,Medina JH. Regulation of peripheraltype benzodiazepine receptors following repeated benzodiazepine administration. Funct Neurol 1992;7:227-230
27. Miller LG, Greenblatt DJ, Barnhill JG, Shader RI. Chronicben zodiazepine administration. I. Tolerance is associated with benzodiazepine receptor downregulation and decreased gammaaminobutyric acid A receptor function. J Pharmacol Exp Ther 1988;246:170-176
28. Cornu P, Benavides J, Scatton B, Hauw JJ, Philippon J. Increase in ω3 (peripheral-type benzodiazepine) binding site densities in different types of human brain tumours. A quantitative autoradiography study. Acta Neurochir 1992; 119:146-152 (Pubitemid 23022785)
29. Hardwick M, Fertikh D, Culty M, Li H, Vidic B, Papadopoulos V. Peripheral-type benzodiazepine receptor (PBR) in human breast cancer: correlation of breast cancer cell aggressive phenotype with PBR expression, nuclear localization, and PBR-mediated cell proliferation and nuclear transport of cholesterol. Cancer Res 1999;59:831-842 (Pubitemid 29086736)
30. Beinlich A, Strohmeier R, Kaufmann M, Kuhl H. Specific binding of benzodiazepines to human breast cancer cell lines. Life Sci 1999;65:2099-2108 (Pubitemid 29524859)
31. Garnier M, Dimchev AB, Boujrad N, Price JM, Musto NA, Papadopoulos V. In vitro reconstitution of a functional peripheral-type benzodiazepine receptor from mouse Leydig tumor cells. Mol Pharmacol 1994;45:201-211
32. Le Fur G, Vaucher N, Perrier ML, et al. Differentiation between two ligands for peripheral benzodiazepine binding sites, [3H]RO5-4864 and [3H]PK 11195, by thermodynamic studies. Life Sci 1983;33:449-457
33. Cohn JB, Wilcox CS. Long-term comparison of alprazolam, lorazepam and placebo in patients with an anxiety disorder. Pharmacotherapy 1984;2:93-98 (Pubitemid 14148711)